These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
518 related items for PubMed ID: 24408897
1. 11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy. Giovacchini G, Picchio M, Garcia-Parra R, Briganti A, Abdollah F, Gianolli L, Schindler C, Montorsi F, Messa C, Fazio F. J Nucl Med; 2014 Feb; 55(2):233-41. PubMed ID: 24408897 [Abstract] [Full Text] [Related]
5. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. Kitajima K, Murphy RC, Nathan MA, Froemming AT, Hagen CE, Takahashi N, Kawashima A. J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294 [Abstract] [Full Text] [Related]
6. Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy. Giovacchini G, Picchio M, Parra RG, Briganti A, Gianolli L, Montorsi F, Messa C. Clin Nucl Med; 2012 Apr; 37(4):325-31. PubMed ID: 22391699 [Abstract] [Full Text] [Related]
7. Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes? Incerti E, Fodor A, Mapelli P, Fiorino C, Alongi P, Kirienko M, Giovacchini G, Busnardo E, Gianolli L, Di Muzio N, Picchio M. J Nucl Med; 2015 Dec; 56(12):1836-42. PubMed ID: 26405166 [Abstract] [Full Text] [Related]
8. Correlation of [11C]choline PET-CT with time to treatment and disease-specific survival in men with recurrent prostate cancer after radical prostatectomy. Breeuwsma AJ, Rybalov M, Leliveld AM, Pruim J, de Jong IJ. Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):440-6. PubMed ID: 23069923 [Abstract] [Full Text] [Related]
10. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. Castellucci P, Fuccio C, Nanni C, Santi I, Rizzello A, Lodi F, Franceschelli A, Martorana G, Manferrari F, Fanti S. J Nucl Med; 2009 Sep; 50(9):1394-400. PubMed ID: 19690023 [Abstract] [Full Text] [Related]
13. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure? Goldstein J, Even-Sapir E, Ben-Haim S, Saad A, Spieler B, Davidson T, Berger R, Weiss I, Appel S, Lawrence YR, Symon Z. Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322 [Abstract] [Full Text] [Related]
15. PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy. Giovacchini G, Picchio M, Scattoni V, Garcia Parra R, Briganti A, Gianolli L, Montorsi F, Messa C. Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1106-16. PubMed ID: 20306038 [Abstract] [Full Text] [Related]